|
Apr 26
|
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
|
|
Apr 26
|
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
|
|
Apr 26
|
Q1 2024 Bristol-Myers Squibb Co Earnings Call
|
|
Apr 25
|
Bristol Myers Squibb stock tumbles on cost-cutting initiative
|
|
Apr 25
|
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
|
|
Apr 25
|
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
|
|
Apr 25
|
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
|
|
Apr 25
|
Update: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall
|
|
Apr 25
|
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
|
|
Apr 25
|
Why Bristol Myers Squibb Stock Is Sinking Today
|
|
Apr 25
|
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
|
|
Apr 25
|
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
|
|
Apr 25
|
Bristol-Myers Squibb to Cut 2,200 Jobs as Part of $1.5 Billion Cost-Cutting Effort
|
|
Apr 25
|
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
|
|
Apr 25
|
Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts
|
|
Apr 25
|
Is Bristol Myers Squibb Stock a Millionaire Maker?
|
|
Apr 25
|
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Apr 25
|
Bristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed Overview
|
|
Apr 25
|
UPDATE 2-Bristol Myers posts quarterly loss, revenue rises 5%
|
|
Apr 25
|
Bristol Myers posts quarterly loss, lays out $1.5 billion cost-saving plan
|